Article
NF1, Neurofibromin and Gene Therapy: Prospects of Next-Generation Therapy.
Current gene therapy - 1 Jan 2020
Cui Xi-Wei, Ren Jie-Yi, Gu Yi-Hui, Li Qing-Feng, Wang Zhi-Chao
Abstract excerpt
Neurofibromatosis type 1 [NF1] is an autosomal dominant genetic disorder affecting multiple organs. NF1 is well known for its various clinical manifestations, including café-au-late macules, Lisch nodules, bone deformity and neurofibromas. However, there is no effective therapy for NF1. Current therapies are aimed at alleviating NF1 clinical symptoms but not curing the disease. By altering pathogenic genes, gene...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
